584 related articles for article (PubMed ID: 27638540)
1. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
[TBL] [Abstract][Full Text] [Related]
2. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
[TBL] [Abstract][Full Text] [Related]
3. CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.
Tupikowski K; Partyka A; Kolodziej A; Dembowski J; Debinski P; Halon A; Zdrojowy R; Frydecka I; Karabon L
Tissue Antigens; 2015 Nov; 86(5):353-61. PubMed ID: 26403483
[TBL] [Abstract][Full Text] [Related]
4. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
[TBL] [Abstract][Full Text] [Related]
5. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population.
Pawlak E; Karabon L; Wlodarska-Polinska I; Jedynak A; Jonkisz A; Tomkiewicz A; Kornafel J; Stepien M; Ignatowicz A; Lebioda A; Dobosz T; Frydecka I
Hum Immunol; 2010 Feb; 71(2):195-200. PubMed ID: 19913589
[TBL] [Abstract][Full Text] [Related]
6. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
Daroszewski J; Pawlak E; Karabon L; Frydecka I; Jonkisz A; Slowik M; Bolanowski M
Eur J Endocrinol; 2009 Nov; 161(5):787-93. PubMed ID: 19734241
[TBL] [Abstract][Full Text] [Related]
7. Variations in suppressor molecule ctla-4 gene are related to susceptibility to multiple myeloma in a polish population.
Karabon L; Pawlak-Adamska E; Tomkiewicz A; Jedynak A; Kielbinski M; Woszczyk D; Potoczek S; Jonkisz A; Kuliczkowski K; Frydecka I
Pathol Oncol Res; 2012 Apr; 18(2):219-26. PubMed ID: 21744007
[TBL] [Abstract][Full Text] [Related]
8. The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population.
Torres-Carrillo N; Ontiveros-Mercado H; Torres-Carrillo NM; Parra-Rojas I; Rangel-Villalobos H; Ramírez-Dueñas MG; Gutiérrez-Ureña SR; Valle Y; Muñoz-Valle JF
Cell Biochem Biophys; 2013; 67(3):1217-28. PubMed ID: 23703660
[TBL] [Abstract][Full Text] [Related]
9. Is the Genetic Background of Co-Stimulatory CD28/CTLA-4 Pathway the Risk Factor for Prostate Cancer?
Karabon L; Tupikowski K; Tomkiewicz A; Partyka A; Pawlak-Adamska E; Wojciechowski A; Kolodziej A; Dembowski J; Zdrojowy R; Frydecka I
Pathol Oncol Res; 2017 Oct; 23(4):837-843. PubMed ID: 28101800
[TBL] [Abstract][Full Text] [Related]
10. Correlation between CTLA-4 and CD40 gene polymorphisms and their interaction in graves' disease in a Chinese Han population.
Chen X; Hu Z; Liu M; Li H; Liang C; Li W; Bao L; Chen M; Wu G
BMC Med Genet; 2018 Sep; 19(1):171. PubMed ID: 30223781
[TBL] [Abstract][Full Text] [Related]
11. Association of CTLA-4 +49 A/G and CT60 Gene Polymorphism with Graves' Disease.
Fouad NA; Saeed AM; Mahedy AW
Egypt J Immunol; 2017 Jun; 24(2):63-70. PubMed ID: 29528580
[TBL] [Abstract][Full Text] [Related]
12. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Tomer Y; Davies TF
Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
[TBL] [Abstract][Full Text] [Related]
13. CD28, CTLA-4 and CCL5 gene polymorphisms in patients with rheumatoid arthritis.
Luterek-Puszyńska K; Malinowski D; Paradowska-Gorycka A; Safranow K; Pawlik A
Clin Rheumatol; 2017 May; 36(5):1129-1135. PubMed ID: 27988812
[TBL] [Abstract][Full Text] [Related]
14. Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children.
Chong KK; Chiang SW; Wong GW; Tam PO; Ng TK; Hu YJ; Yam GH; Lam DS; Pang CP
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2409-15. PubMed ID: 18296657
[TBL] [Abstract][Full Text] [Related]
15. Long-term remission following antithyroid drug withdrawal in patients with Graves' hyperthyroidism: parameters with prognostic value.
García-Mayor RV; Álvarez-Vázquez P; Fluiters E; Valverde D; Andrade A
Endocrine; 2019 Feb; 63(2):316-322. PubMed ID: 30334140
[TBL] [Abstract][Full Text] [Related]
16. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
Zhang Q; Yang YM; Lv XY
J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
[TBL] [Abstract][Full Text] [Related]
17. Genetic Variation of Costimulatory Molecules, Including Cytotoxic T-Lymphocyte Antigen 4, Inducible T-Cell Costimulator, Cluster Differentiation 28, and Programmed Cell Death 1 Genes, in Iranian Patients With Leukemia.
Ramzi M; Arandi N; Saadi MI; Yaghobi R; Geramizadeh B
Exp Clin Transplant; 2020 Nov; 18(6):719-724. PubMed ID: 29697355
[TBL] [Abstract][Full Text] [Related]
18. Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Davies TF
Thyroid; 2012 Jul; 22(7):730-6. PubMed ID: 22663548
[TBL] [Abstract][Full Text] [Related]
19. Association and gene-gene interaction analyses for polymorphic variants in CTLA-4 and FOXP3 genes: role in susceptibility to autoimmune thyroid disease.
Fathima N; Narne P; Ishaq M
Endocrine; 2019 Jun; 64(3):591-604. PubMed ID: 30771152
[TBL] [Abstract][Full Text] [Related]
20. Synergistic combined effect between CD40-1C>T and CTLA-4+6230G>A polymorphisms in Graves' disease.
Chen X; Hu Z; Li W; Wu P; Liu M; Bao L; Wu M; Fang S; Xiong W; Chen M; Wu G
Gene; 2015 Aug; 567(2):154-8. PubMed ID: 25936345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]